María Auxiliadora Bajo, Francisco Ríos-Moreno, Maria Dolores Arenas, Ramón Jesús Devesa-Such, Maria Jose Molina-Higueras, Margarita Delgado, Pablo Molina, Nuria García-Fernández, Alejandro Martin-Malo, Roser Peiró-Jordán, Jorge Cannata-Andia, Ángel Luis Martín-De Francisco
BACKGROUND AND AIMS: In this study, we show the results of the subset of Spanish patients of the VERIFIE study, the first post-marketing study assessing the long-term safety and effectiveness of sucroferric oxyhydroxide (SFOH) in patients with hyperphosphatemia undergoing dialysis during clinical practice. PATIENTS AND METHODS: Patients undergoing hemodialysis and peritoneal dialysis with indication of SFOH treatment were included. Follow-up duration was 12-36 months after SFOH initiation...
February 2, 2023: Nefrología